Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Jayamas Medica Industri TbkISX:OMED +0.94%93 PB Ratio is 2.05 as of Jul. 30, 2026, which is 8% below its 10-year median of 2.23. GuruFocus rates ISX:OMED with a GF Score™ of 93/100 and a GF Value™ of Rp239.04 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, PT Jayamas Medica Industri Tbk ranks worse than 50.19% on this metric.
The historical rank and industry rank for PT Jayamas Medica Industri Tbk's PB Ratio or its related term are showing as below:
ISX:OMED'
s PB Ratio Range Over the Past 10 Years
Min: 1.62 Med: 2.23 Max: 2.99
Current: 2.05
During the past 7 years, PT Jayamas Medica Industri Tbk's highest PB Ratio was 2.99. The lowest was 1.62. And the median was 2.23.
ISX:OMED's PB Ratio is ranked worse than 50.19% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs ISX:OMED: 2.05
During the past 12 months, PT Jayamas Medica Industri Tbk's average Book Value Per Share Growth Rate was 11.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 10.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 23.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of PT Jayamas Medica Industri Tbk was 53.80% per year. The lowest was 10.10% per year. And the median was 29.70% per year.
Back to Basics: PB Ratio
PT Jayamas Medica Industri Tbk (ISX:OMED) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PT Jayamas Medica Industri Tbk PB Ratio Related Terms
PT Jayamas Medica Industri Tbk PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Jayamas Medica Industri Tbk PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's PB Ratio distribution charts can be found below:
* The bar in red indicates where PT Jayamas Medica Industri Tbk's PB Ratio falls into.
PT Jayamas Medica Industri Tbk PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PT Jayamas Medica Industri Tbk (ISX:OMED) has a PB Ratio of 2.05 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PT Jayamas Medica Industri Tbk and its competitors. This is near median its historical median of 2.23. Over the past decade, PT Jayamas Medica Industri Tbk's PB Ratio has ranged from 1.62 to 2.99. According to the industry distribution chart, PT Jayamas Medica Industri Tbk ranks #395 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 50.2%.
Is PT Jayamas Medica Industri Tbk's PB Ratio too high?
PT Jayamas Medica Industri Tbk's current PB Ratio of 2.05 is near median its 10-year median of 2.23. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 2.99. The Medical Devices & Instruments industry median PB Ratio is 2.04. PT Jayamas Medica Industri Tbk's value of 2.05 is 0.5% above this industry median. Based on the distribution chart, PT Jayamas Medica Industri Tbk ranks #395 out of 787 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PT Jayamas Medica Industri Tbk has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Jayamas Medica Industri Tbk's PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Jayamas Medica Industri Tbk ranks #395 out of 787 companies for PB Ratio. This places PT Jayamas Medica Industri Tbk in the lower half of its industry. The industry median PB Ratio is 2.04. PT Jayamas Medica Industri Tbk's value of 2.05 is 0.5% above this benchmark. Historically, PT Jayamas Medica Industri Tbk's own PB Ratio has ranged from 1.62 to 2.99 over the past decade. While the company's 10-year median is 2.23 vs. the industry median of 2.04, PT Jayamas Medica Industri Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Jayamas Medica Industri Tbk's current PB Ratio of 2.05 is 0.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PT Jayamas Medica Industri Tbk and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Jayamas Medica Industri Tbk's current PB Ratio is 2.05, which is near median its own 10-year median of 2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Jayamas Medica Industri Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk (ISX:OMED) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp239.04, compared to a current price of Rp214.00 — trading 10.5% below its estimated fair value. The current PB Ratio is 2.05, which is near median its 10-year median of 2.23 and 0.5% above the Medical Devices & Instruments industry median of 2.04. PT Jayamas Medica Industri Tbk's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PT Jayamas Medica Industri Tbk (ISX:OMED), the current PB Ratio is 2.05 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Jayamas Medica Industri Tbk (ISX:OMED) Overvalued in 2026?
Based on GuruFocus' analysis, PT Jayamas Medica Industri Tbk stock appears to be undervalued.
The current stock price of Rp214.00 is trading 10.5% below its estimated GF Value™ of Rp239.04.
GuruFocus considers PT Jayamas Medica Industri Tbk to be Modestly Undervalued.
Key valuation signals for ISX:OMED:
PB Ratio: 2.05 (near median its 10-year median of 2.23)
GF Value™: Rp239.04 vs. price of Rp214.00 (10.5% below fair value)
Industry Position: 0.5% above the Medical Devices & Instruments median (#395 of 787)
No single metric tells the full story. See the ISX:OMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Jayamas Medica Industri Tbk Business Description
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing, wholesale and retail trade of medical devices. Its offerings include Disposable and Expendable Medical Supplies, Wound Care, Diagnostics and Equipment, Antiseptics and Dialysis, Biotechnology and Laboratory, Ambulatory and Rehabilitation Care The company has three segments: i) Manufacturing: This division is involved in the manufacturing of medical supplies and equipment, ii) Distribution: This division is involved with the large scale distribution of medical supplies and equipment at strategic locations, iii) Retail: This division is involved with the retail of medical supplies and equipment through Medicom stores and online platforms. The majority of the company's revenue is derived from the Distribution segment.
93GF Score
Get the complete analysis for ISX:OMED
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:OMED has been successfully added to your 
